Forrest, Marc
2013.
The function of TCF4 in Pitt-Hopkins syndrome and schizophrenia.
PhD Thesis,
Cardiff University.
Item availability restricted. |
Preview |
PDF
- Accepted Post-Print Version
Download (6MB) | Preview |
![]() |
PDF
- Supplemental Material
Restricted to Repository staff only Download (1MB) |
Abstract
Genome-wide association studies have identified TCF4 (transcription factor 4) as a susceptibility gene for schizophrenia. In addition, rare TCF4 mutations cause Pitt Hopkins syndrome (PTHS), a severe form of intellectual disability associated with characteristic facial features, developmental delay and autonomic dysfunction. TCF4 belongs to the basic helix-loop-helix family (bHLH) of transcription factors that play a central role in development, however the precise function of this gene in the brain is unknown. In this study, I use molecular and cellular techniques to improve our understanding of TCF4 function in the brain. Modeling of PTHS-associated missense mutations in transfected cells showed that TCF4 mutations affecting the DNA-binding domain cause mislocalisation of the mutant protein. DNA-binding domain mutations also impaired dimerisation and attenuated transcriptional activity at the NRXN1 and CNTNAP2 promoters. TCF4 mutations affecting other domains of the protein had context-specific deficits in dimerisation and transactivation under the same conditions. Microarray analysis of SH-SY5Y cells where all TCF4 isoforms had been knocked down identified gene expression changes affecting cellular processes including epithelial-to-mesenchymal transition, apoptosis and neurodevelopment. However, isoform-specific knockdown experiments showed that TCF4-A and TCF4-B isoforms affect distinct biological processes such as the cell cycle, chromatin modification (TCF4-B), cell adhesion and cytoskeletal remodeling (TCF4-A). Finally, mass spectrometry was used to identify TCF4-associated proteins in SHSY5Y cells. These experiments showed that TCF4-B and TCF4-A co-purified with proteins involved in chromatin organization, cell cycle control and RNA splicing. In addition to the bHLH factors HAND2 and TWIST2, TCF4 co-purified with components of the nuclear co-repressor complex. TCF4 also has multiple phosphorylation sites in both activation domains suggesting that TCF4 function may be regulated by kinase signaling. In conclusion, these data provide a mechanistic insight into the function of TCF4 that may advance our understanding of disease processes in PTHS and schizophrenia.
Item Type: | Thesis (PhD) |
---|---|
Status: | Unpublished |
Schools: | Medicine |
Subjects: | R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry |
Date of First Compliant Deposit: | 30 March 2016 |
Last Modified: | 25 Mar 2016 01:30 |
URI: | https://orca.cardiff.ac.uk/id/eprint/58210 |
Actions (repository staff only)
![]() |
Edit Item |